Lucio Morabito

1.4k total citations
35 papers, 735 citations indexed

About

Lucio Morabito is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Lucio Morabito has authored 35 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 13 papers in Oncology and 10 papers in Genetics. Recurrent topics in Lucio Morabito's work include Hematopoietic Stem Cell Transplantation (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Lucio Morabito is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Lucio Morabito collaborates with scholars based in Italy, France and Spain. Lucio Morabito's co-authors include Regina Resta, Ronald van Vollenhoven, Edgar G. Engleman, Leonie J. T. Balter, Linda F. Thompson, Bruce N. Cronstein, James L. McGuire, Gunnar Carlin, M. Carmen Montesinos and Barbara Sarina and has published in prestigious journals such as Journal of Clinical Investigation, Blood and British Journal of Haematology.

In The Last Decade

Lucio Morabito

34 papers receiving 720 citations

Peers

Countries citing papers authored by Lucio Morabito

Since Specialization

Citations

This map shows the geographic impact of Lucio Morabito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucio Morabito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucio Morabito more than expected).

Fields of papers citing papers by Lucio Morabito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucio Morabito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucio Morabito. The network helps show where Lucio Morabito may publish in the future.

Co-authorship network of co-authors of Lucio Morabito

This figure shows the co-authorship network connecting the top 25 collaborators of Lucio Morabito. A scholar is included among the top collaborators of Lucio Morabito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucio Morabito. Lucio Morabito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma 2021 ·Drug Design Development and Therapy ·Fortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, Ernesto Vigna, Francesco Mendicino, Lucio Morabito, Katia Todoerti, (unknown), Graziella D’Arrigo, (unknown), Giovanna Cutrona, Antonino Neri, Massimo Martino, Massimo Gentile	12
2	An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma 2019 ·Expert Opinion on Pharmacotherapy ·Fortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, Cirino Botta, (unknown), (unknown), (unknown), Sara Galimberti, Lucio Morabito, (unknown), Massimo Martino, Giovanna Cutrona, Massimo Gentile	3
3	Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 2019 ·Cancer Medicine ·Jacopo Mariotti, Daniela Taurino, (unknown), Stéfania Bramanti, Barbara Sarina, Lucio Morabito, Chiara De Philippis, Clara Di Vito, Domenico Mavilio, Carmelo Carlo‐Stella, Matteo Giovanni Della Porta, Armando Santoro, Luca Castagna	12
4	Genomic integration of HHV-6 mimicking viral reactivation after autologous stem cell transplantation 2018 ·Mediterranean Journal of Hematology and Infectious Diseases ·Rossana Mineri, Jacopo Mariotti, Barbara Sarina, Lucio Morabito, Roberto Crocchiolo, Stéfania Bramanti, (unknown), Federica Tordato, Carmelo Carlo‐Stella, Armando Santoro, Luca Castagna	1
5	T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors 2017 ·Biology of Blood and Marrow Transplantation ·Jacopo Mariotti, Raynier Devillier, Stéfania Bramanti, Barbara Sarina, Sabine Fürst, Angéla Granata, Catherine Faucher, Samia Harbi, Lucio Morabito, Christian Chabannon, Carmelo Carlo‐Stella, Réda Bouabdallah, Armando Santoro, Didier Blaise, Luca Castagna	32
6	Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma 2017 ·Bone Marrow Transplantation ·Luca Castagna, Stéfania Bramanti, Raynier Devillier, Barbara Sarina, Roberto Crocchiolo, Sabine Fürst, Jean El Cheikh, Angéla Granata, Catherine Faucher, (unknown), Lucio Morabito, Jacopo Mariotti, (unknown), Pierre Jean Weiller, Christian Chabannon, Djamel Mokart, Carmelo Carlo‐Stella, Réda Bouabdallah, Armando Santoro, Didier Blaise	31
7	Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation 2016 ·Bone Marrow Transplantation ·Luca Castagna, Barbara Sarina, Roberto Crocchiolo, Stéfania Bramanti, Sabine Fürst, Raynier Devillier, Diane Coso, Réda Bouabdallah, Djamel Mokart, Lucio Morabito, (unknown), Laura Giordano, (unknown), P.J. Weiller, Carmelo Carlo‐Stella, Armando Santoro, Christian Chabannon, Didier Blaise	4
8	Sorafenib for the treatment of multiple myeloma 2016 ·Expert Opinion on Investigational Drugs ·Massimo Gentile, Massimo Martino, Anna Grazia Recchia, Ernesto Vigna, Lucio Morabito, Fortunato Morabito	11
9	Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor 2016 ·Journal of Clinical Virology ·Roberto Crocchiolo, Laura Giordano, (unknown), (unknown), Barbara Sarina, Lucio Morabito, Stéfania Bramanti, Luca Castagna, Rossana Mineri	16
10	Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation 2016 ·Transfusion ·Stéfania Bramanti, Angela Nocco, Elisa Mauro, Giuseppe Milone, Lucio Morabito, Barbara Sarina, Roberto Crocchiolo, Inna Timofeeva, (unknown), Carmelo Carlo‐Stella, Armando Santoro, Luca Castagna	11
11	T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 2015 ·Bone Marrow Transplantation ·Raynier Devillier, Stéfania Bramanti, Sabine Fürst, Barbara Sarina, Jean El Cheikh, Roberto Crocchiolo, Angéla Granata, Christian Chabannon, Lucio Morabito, (unknown), C. Faucher, Armando Santoro, (unknown), Norbert Vey, Carmelo Carlo‐Stella, Luca Castagna, Didier Blaise	18
12	Ixazomib for the treatment of multiple myeloma 2015 ·Expert Opinion on Investigational Drugs ·Massimo Gentile, Massimo Offidani, Ernesto Vigna, Laura Corvatta, Anna Grazia Recchia, Lucio Morabito, Fortunato Morabito, Silvia Gentili	41
13	Smoldering multiple myeloma: to treat or not to treat 2015 ·Expert Opinion on Pharmacotherapy ·Massimo Gentile, Massimo Offidani, Ernesto Vigna, Laura Corvatta, Anna Grazia Recchia, Lucio Morabito, Massimo Martino, Fortunato Morabito, Silvia Gentili	4
14	The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients 2015 ·Blood ·Roberto Crocchiolo, Luca Castagna, Sabine Fürst, Raynier Devillier, Barbara Sarina, Stéfania Bramanti, Jean El Cheikh, Angéla Granata, Samia Harbi, Lucio Morabito, Catherine Faucher, (unknown), Bilal Mohty, Pierre Jean Weiller, Carmelo Carlo‐Stella, Christian Chabannon, Réda Bouabdallah, Armando Santoro, Norbert Vey, Didier Blaise	2
15	Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas 2014 ·Bone Marrow Transplantation ·Luca Castagna, Stéfania Bramanti, S. Fürst, Laura Giordano, Roberto Crocchiolo, Barbara Sarina, Ernesto Di Mauro, Lucio Morabito, Réda Bouabdallah, Diane Coso, Monica Balzarotti, Florence Broussais, Jean El Cheikh, (unknown), Ercole Brusamolino, Didier Blaise, Armando Santoro	26
16	An old drug with a new future: bendamustine in multiple myeloma 2013 ·Expert Opinion on Pharmacotherapy ·Massimo Gentile, Anna Grazia Recchia, Carla Mazzone, Ernesto Vigna, Massimo Martino, Lucio Morabito, Eugenio Lucia, Sabrina Bossio, Laura De Stefano, (unknown), (unknown), Fortunato Morabito	12
17	Janus kinase 2 inhibitors in myeloproliferative disorders 2010 ·Expert Opinion on Investigational Drugs ·Eugenio Lucia, Anna Grazia Recchia, Massimo Gentile, Sabrina Bossio, Ernesto Vigna, Carla Mazzone, Antonio Madeo, Lucio Morabito, (unknown), Laura De Stefano, (unknown), (unknown), (unknown), Maria Grazia Bisconte, (unknown), Fortunato Morabito	13
18	Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy 2008 ·International Journal of Hematology ·(unknown), (unknown), Tara Martin, Lucio Morabito, Miguel Brito, (unknown)	13
19	Expression of nuclear insulin receptor substrate 1 in breast cancer 2006 ·Journal of Clinical Pathology ·Diego Sisci, Catia Morelli, Cecilia Garofalo, Francesco Romeo, Lucio Morabito, (unknown), Emilia Middea, Sandra Cascio, Elvira Brunelli, Sebastiano Andò, Eva Surmacz	36
20	Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. 1998 ·Journal of Clinical Investigation ·Lucio Morabito, M. Carmen Montesinos, (unknown), Leonie J. T. Balter, Linda F. Thompson, Regina Resta, Gunnar Carlin, (unknown), Bruce N. Cronstein	206

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact